Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Sanofi Reports 9.9% Sales Growth to EUR 43.6B, Driven by Dupixent and China
Company

Sanofi Reports 9.9% Sales Growth to EUR 43.6B, Driven by Dupixent and China

January 30, 2026
Roche Reports 7% Sales Growth to CHF 61.5B, Driven by Pharma and China
Company

Roche Reports 7% Sales Growth to CHF 61.5B, Driven by Pharma and China

April 10, 2026
United Labs TUL108 Gets FDA Nod for Antibiotic Resistance Trial
CompanyDrug

United Labs TUL108 Gets FDA Nod for Antibiotic Resistance Trial

January 29, 2026
Fosun Pharma Licenses HPV DNA Drug VGX-3100 from ApolloBio for Greater China
CompanyDeals

Fosun Pharma Licenses HPV DNA Drug VGX-3100 from ApolloBio for Greater China

February 26, 2026
Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform
CompanyDeals

Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform

January 29, 2026
Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered
CompanyDeals

Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered

January 29, 2026
WuXi Biologics Partners with Sinorda on SND006 Bispecific Antibody for Autoimmune Diseases
CompanyDeals

WuXi Biologics Partners with Sinorda on SND006 Bispecific Antibody for Autoimmune Diseases

January 29, 2026
NeuShen Therapeutics Raises Series A+ for CNS Drug Development
CompanyDeals

NeuShen Therapeutics Raises Series A+ for CNS Drug Development

January 29, 2026
Organon Completes $465M JADA System Sale to Laborie Medical
CompanyDeals

Organon Completes $465M JADA System Sale to Laborie Medical

January 29, 2026
MicuRx MRX-5 Gets FDA Nod for Phase II NTM Lung Disease Study
CompanyDrug

MicuRx MRX-5 Gets FDA Nod for Phase II NTM Lung Disease Study

January 29, 2026
Huiyu Pharma HYP-6589 Gets NMPA Nod for NSCLC Osimertinib Combo
CompanyDrug

Huiyu Pharma HYP-6589 Gets NMPA Nod for NSCLC Osimertinib Combo

January 29, 2026
Servier Oncology Revenue Drives 16% Growth, US Sales Surge 70%
Company

Servier Oncology Revenue Drives 16% Growth, US Sales Surge 70%

January 29, 2026
1 2 3 4 … 22 23
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up